3,4-dihydroxyphenylacetic acid has been researched along with quercetin in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 6 (31.58) | 2.80 |
Authors | Studies |
---|---|
Bücherl, D; Decker, M; Heilmann, J; Kling, B; Matysik, FM; Palatzky, P; Wegener, J | 1 |
Campbell, D; Gross, M; Martini, M; Pfeiffer, M; Potter, J; Slavin, J | 1 |
Coutts, RT; Durkin, J; Morley, P; Pang, PK; Shan, JJ; Sloley, BD; Urichuk, LJ | 1 |
Blaut, M; Hartmann, L; Pforte, H; Schneider, H; Simmering, R | 1 |
Aura, AM; Bailey, M; Nuutila, AM; O'Leary, KA; Ojala, M; Oksman-Caldentey, KM; Poutanen, K; Puupponen-Pimiä, R; Williamson, G | 1 |
Konishi, Y | 1 |
Aruoma, OI; Datla, KP; Dexter, DT; Parkar, S; Rai, DK; Zbarsky, V | 1 |
Butterweck, V; Kelber, O; Nieber, K; Vissiennon, C | 1 |
Carrasco-Pozo, C; Castillo, RL; Chen, C; Gotteland, M | 1 |
Jiang, Z; Wang, J; Wang, M; Xie, W; Xue, H; Zhang, X; Zhao, H | 1 |
Giménez-Bastida, JA; Piskula, M; Szawara-Nowak, D; Zielinska, D; Zielinski, H | 1 |
Mladěnka, P; Najmanová, I; Pourová, J | 1 |
Butterweck, V; Hamburger, M; Oufir, M; Sampath, C; Zabela, V | 1 |
Carrasco-Pozo, C; Catalán, M; Ferreira, J | 1 |
Ambat, A; Bhat, GJ; Jose, D; Nelson, J; Sankaranarayanan, R; Scaria, J; Sekhon, PK | 1 |
Ekiert, H; Jafernik, K; Kikowska, M; Klimek-Szczykutowicz, M; Studzińska-Sroka, E; Szopa, A; Thiem, B | 1 |
Campos-Vega, R; García-Gutiérrez, N; García-Solis, P; Herrera-Hernández, G; Lozano-Herrera, SJ; Luna-Bárcenas, G; Sánchez-Tusié, AA; Vergara-Castañeda, HA | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
19 other study(ies) available for 3,4-dihydroxyphenylacetic acid and quercetin
Article | Year |
---|---|
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Flavonoids; Hippocampus; Hydroxybenzoates; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxidative Stress; Quercetin | 2014 |
The quantitation of metabolites of quercetin flavonols in human urine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Anticarcinogenic Agents; Biomarkers; Chromatography, High Pressure Liquid; Diet; Epidemiologic Methods; Feasibility Studies; Flavonoids; Flavonols; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Male; Neoplasms; Phenylacetates; Quercetin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1996 |
Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Brain; Cells, Cultured; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Flavonoids; Ginkgo biloba; Hydroxyindoleacetic Acid; Kaempferols; Lipid Peroxidation; Liver; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Neuroprotective Agents; Norepinephrine; Plant Extracts; Plant Leaves; Plants, Medicinal; Quercetin; Rats; Rats, Sprague-Dawley; Serotonin; Tumor Cells, Cultured | 2000 |
Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biotransformation; Cecum; Colon; Colony Count, Microbial; Enterococcus; Eubacterium; Feces; Flavonols; Gastrointestinal Contents; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Jejunum; Quercetin; Random Allocation; Rats; Rats, Inbred Strains | 2000 |
Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anaerobiosis; Chromatography, High Pressure Liquid; Feces; Fermentation; Humans; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Methylation; Quercetin; Rutin | 2002 |
Transepithelial transport of microbial metabolites of quercetin in intestinal Caco-2 cell monolayers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biological Transport; Caco-2 Cells; Diffusion; Epithelium; Homovanillic Acid; Humans; Intestinal Mucosa; Monocarboxylic Acid Transporters; Phenylacetates; Quercetin | 2005 |
Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Curcumin; Disease Models, Animal; Dopamine; Flavanones; Flavonoids; Flavonols; Homovanillic Acid; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phenols; Quercetin; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2005 |
Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin--are they prodrugs?
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Anti-Anxiety Agents; Diazepam; Dose-Response Relationship, Drug; Flavonoids; Injections, Intraperitoneal; Kaempferols; Male; Mice; Mice, Inbred C57BL; Phenylacetates; Prodrugs; Quercetin | 2012 |
3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cells, Cultured; Cholesterol; Dose-Response Relationship, Drug; Insulin-Secreting Cells; Mice; Quercetin; Structure-Activity Relationship | 2015 |
3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Mice; Microbiota; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; Quercetin | 2016 |
Buckwheat bioactive compounds, their derived phenolic metabolites and their health benefits.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antioxidants; Cell Line; Chelating Agents; Chemokine CCL2; Cyclooxygenase 2; Dinoprostone; Fagopyrum; Gastroenteritis; Glycation End Products, Advanced; Homovanillic Acid; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Intestines; Phenylacetates; Quercetin; Rutin | 2017 |
A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Catechols; Coumaric Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Phenols; Quercetin; Rats; Rats, Inbred SHR | 2020 |
Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Intravenous; Animals; Male; Phenylacetates; Quercetin; Rats, Sprague-Dawley | 2020 |
The Microbiota-Derived Metabolite of Quercetin, 3,4-Dihydroxyphenylacetic Acid Prevents Malignant Transformation and Mitochondrial Dysfunction Induced by Hemin in Colon Cancer and Normal Colon Epithelia Cell Lines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antineoplastic Agents; Apoptosis; Biological Products; Cell Line; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Electron Transport Complex I; Electron Transport Complex II; Hemin; Humans; Intestinal Mucosa; Microbiota; Mitochondria; Oxidation-Reduction; Quercetin; Reactive Oxygen Species | 2020 |
Screening of Human Gut Bacterial Culture Collection Identifies Species That Biotransform Quercetin into Metabolites with Anticancer Properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Actinobacteria; Antineoplastic Agents; Bacillus; Bacteria; Bacterial Proteins; Bacteroides; Bromobenzoates; Cell Proliferation; Cell Survival; Clostridiales; Eubacterium; Gallic Acid; Gastrointestinal Microbiome; Gene Expression Profiling; Gene Expression Regulation, Bacterial; HCT116 Cells; Humans; Hydroxybenzoates; Phylogeny; Quercetin; Sequence Analysis, RNA | 2021 |
Effect of Elicitation with (+)-Usnic Acid on Accumulation of Phenolic Acids and Flavonoids in Agitated Microshoots of
Topics: 3,4-Dihydroxyphenylacetic Acid; Benzofurans; Biomass; Caffeic Acids; Chromatography, High Pressure Liquid; Cinnamates; Depsides; Eryngium; Flavonoids; Hydroxybenzoates; Plant Growth Regulators; Plant Shoots; Quercetin; Rosmarinic Acid | 2021 |
Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antioxidants; Benzhydryl Compounds; Cell Proliferation; Colonic Neoplasms; HT29 Cells; Humans; Quercetin | 2023 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |